Danske Bank Share Buy-Back Programme: Transactions In Week 44

2025-11-03 04:01:38

(MENAFN- GlobeNewsWire - Nasdaq)

Company announcement no. 49 2025
Danske Bank
Bernstorffsgade 40
DK-1577 København V
Tel. + 45 33 44 00 00
03 November 2025
Page 1 of 1

Danske Bank share buy-back programme: transactions in week 44
On 7 February 2025, Danske Bank A/S announced a share buy-back programme for a total of DKK 5 billion, with a maximum of 45,000,000 shares, in the period from 10 February 2025 to 30 January 2026, at the latest, as described in company announcement no. 6 2025.
The Programme is carried out in accordance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and Council of 16 April 2014 (the "Market Abuse Regulation") and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the "Safe Harbour Rules").
The following transactions on Nasdaq Copenhagen A/S were made under the share buy-back programme in week 44:

	Number of shares	VWAP DKK	Gross value DKK
Accumulated, last announcement	14,810,516	247.6903	3,668,421,569
27 October 2025	47,000	274.4635	12,899,785
28 October 2025	46,485	276.8238	12,868,154
29 October 2025	45,673	279.6099	12,770,623
30 October 2025	40,000	279.8237	11,192,948
31 October 2025	40,000	286.9201	11,476,804
Total accumulated over week 44	219,158	279.2885	61,208,314
Total accumulated during the share buyback programme	15,029,674	248.1511	3,729,629,882

With the transactions stated above, the total accumulated number of own shares under the share buy-back programme corresponds to 1.800% of Danske Bank A/S' share capital.

Danske Bank
Contact: Claus Ingar Jensen, Head of Group Investor Relations, tel. +45 25 42 43 70

Attachment

Danske Bank Template Company announcementUKWeekly SBB announcement

MENAFN03112025004107003653ID1110284996

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.